» Articles » PMID: 4273650

Mode of Action of a Supernatant Activity from T-cell Cultures That Nonspecifically Stimulates the Humoral Immune Response

Overview
Specialty Science
Date 1974 Feb 1
PMID 4273650
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The mode of action of "allogeneic supernatant" (the culture supernatant of a 24-hr mixedlymphocyte reaction), has been studied. This factor stimulates the response of spleen cell cultures depleted in thymus-derived lymphoid cells (T-cells) to antigens that elicit a thymus-dependent response. We used a limiting dilution analysis, in which the frequency and size of response of individual bone-marrow-derived lymphoid cells (B-cells) could be measured. In confirmation of other reports, the occurrence of B-cells responding to antigen under different conditions was shown to follow a Poisson distribution in mouse spleen cell suspensions. Allogeneic supernatant increased responses to thymus-dependent antigens, both by increasing the frequency of B-cells whose response is initiated and by increasing the numbers of antibody-forming cells obtained from each responding B-cell. Two fractions were obtained by dialysis of the supernatant. The nondialyzable fraction contained factors able to increase both the frequency of B-cells responding to sheep erythrocytes, and the size of the responding unit. The dialysate contained factors that were only able to increase the numbers of antibody-forming cells obtained per responding B-cell from B-cells whose response had already been initiated by antigen-specific T-cells. Since the nondialyzable factors were active in the absence of detectable functional T-cells, it was concluded that these factors, produced by T-cells, might represent one mechanism whereby T-cells cooperate with B-cells in the initiation or development of a humoral immune response.

Citing Articles

Internal histoincompatability during amphibian metamorphosis?.

Jones S, RUBEN L Immunology. 1981; 43(4):741-5.

PMID: 7275177 PMC: 1555097.


Purification and properties of a factor from leukaemic T cells which non-specifically enhances the antibody response.

Mulcahy H, Rubin A, MacDONALD A Immunology. 1981; 42(1):25-35.

PMID: 7007219 PMC: 1458217.


T cell regulation of immunoglobulin class expression in the antibody response to trinitrophenyl-ficoll. Evidence for T cell enhancement of the immunoglobulin class switch.

Mongini P, Paul W, Metcalf E J Exp Med. 1982; 155(3):884-902.

PMID: 6977611 PMC: 2186620. DOI: 10.1084/jem.155.3.884.


Activation of T and B lymphocytes in vitro. II. Biological and biochemical properties of an allogeneic effect factor (AEF) active in triggering specific B lymphocytes.

Armerding D, Katz D J Exp Med. 1974; 140(1):19-37.

PMID: 4545893 PMC: 2139699. DOI: 10.1084/jem.140.1.19.


The modulation of lymphocyte functions by molecules secreted by macrophages. I. Description and partial biochemical analysis.

Calderon J, Kiely J, Lefko J, UNANUE E J Exp Med. 1975; 142(1):151-64.

PMID: 1097572 PMC: 2189883. DOI: 10.1084/jem.142.1.151.


References
1.
RITTENBERG M, AMKRAUT A . Immunogenicity of trinitrophenyl-hemocyanin: production of primary and secondary anti-hapten precipitins. J Immunol. 1966; 97(3):421-30. View

2.
PORTER E, Berry R . THE EFFICIENT DESIGN OF TRANSPLANTABLE TUMOUR ASSAYS. Br J Cancer. 1963; 17:583-95. PMC: 2071224. DOI: 10.1038/bjc.1963.78. View

3.
Shearer G, CUDKOWICZ G, CONNELL M, Priore R . Cellular differentiation of the immune system of mice. I. Separate splenic antigen-sensitive units for different types of anti-sheep antibody-forming cells. J Exp Med. 1968; 128(3):437-57. PMC: 2138534. DOI: 10.1084/jem.128.3.437. View

4.
RITTENBERG M, PRATT K . Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen. Proc Soc Exp Biol Med. 1969; 132(2):575-81. DOI: 10.3181/00379727-132-34264. View

5.
Kettman J, Dutton R . An in vitro primary immune response to 2,4,6-trinitrophenyl substituted erythrocytes: response against carrier and hapten. J Immunol. 1970; 104(6):1558-61. View